| An Interview with Felicia Drury Kliment, Author of Acid Alkaline ...
This interview with Ms. Felicia Drury Kliment, author of Acid Alkaline Balance Diet: An Innovative Program for Ridding Your Body of Acidic Wastes, was conducted via email over the past week.Q) Let me begin by asking you a little more about yourself. Where did you grow up, in particular, and what kind of food did generally eat while growing up?A) I grew up in the late forties and fifties in Youngstown, Ohio, population 100,000. The food additive industry was still in its infancy then, so food was relatively free of pesticides. At the time a well-balanced meal which included the three food types — carbohydrates, fat, and protein — was the byword to good health. A typical dinner was made up of meat, potatoes, vegetables and salad, while a typical breakfast consisted of eggs, bacon, and toast.One of the highlights of my youth was the food we got fresh from a farm or grown in our backyard.
AstraZeneca 4Q profit rises 17 percent
AstraZeneca PLC said Thursday its fourth-quarter profit rose 17 percent, boosted by strong sales of its top five products and cost cutting. But the company said its focus remained on strengthening its weak pipeline of future drugs. The company, which is facing patent challenges and escalating generic competition, also said that it plans to cut 3,000 jobs over the next three years despite predicting continued sales momentum this year. Net profit for the three months to Dec. 31 was $1.4 billion, up from $1.2 billion a year earlier, AstraZeneca said. Revenue rose 14 percent to $7.2 billion. For the full year, profit rose 28.5 percent to $6.04 billion, while sales lifted 11 percent to $26.8 billion. The 2006 results were driven by a 23 percent increase in combined sales of its five key products -- heartburn drug Nexium, schizophrenia treatment Seroquel, cholesterol-lowering treatment Crestor, asthma drug Symbicort and breast cancer treatment Arimidex -- to $13.3 billion.
Drug-coated stents can cause clotting
Christa Butler's drug-coated stent may have saved her life, but it's forced her to continue taking an anti-clotting drug for at least the next six months or risk arterial clotting, a heart attack or even death. Because Butler, a 58-year-old Victoria woman, was implanted in August with that drug-coated stent, she must continue paying $100 a month for Plavix, and that's with insurance. In August, Butler's doctor recommended she take Plavix for about a year, and other doctors nationwide have been instructed to offer similar advice. That's because studies show almost 29 percent of patients who stop using anti-clotting drugs after having a drug-coated stent implanted will have arterial blood clotting, according to the American Heart Association, among others. A drug-coated stent is a tiny, wire-mesh tube that helps to keep arteries open, while emitting a drug.
|
